Commercial leaders vs. other companies in U.S. biotech 2016

This statistic depicts a comparison of commercial leaders vs. other companies in U.S. biotechnology in 2016. In that year, the revenues of commercial leaders amounted to around 99 billion U.S. dollars, while the revenues of other companies in this sector came to some 13.4 billion U.S. dollars.

本统计数据描绘了2016年美国生物技术领域商业领导者与其他公司的对比。在该年度，商业领导者的收入约为999亿美元，而该领域其他公司的收入约为134亿美元。